MEI Pharma announced the completion of a $100 million private sale, selling 29,239,767 shares of common stock or equivalent prepaid warrants at a price of $3.42 per share. The funds raised will be used to establish a Litecoin strategic reserve. The company also appointed Charlie Lee, the founder of Litecoin and the lead investor in this private sale, to join the board of directors, and designated GSR as its digital asset and fund management advisor, responsible for overseeing the execution of the Litecoin reserve strategy. (businesswire)

LTC9.24%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)